Abstract:Background. The application of potent immunosuppressants has decreased the incidence of acute rejection and increased short- and long-term graft survival; however, these drugs cause a variety of complications. In China, many transplant centers have adopted the immunosuppressive protocols based on the white population, neglecting the differences between the races. The purpose of this study was to explore a suitable immunosuppressive regimen for Chinese renal allograft recipients.Methods. Two hundred cadaveric renal allograft recipients who underwent transplantation between July 1999 and October 2001 were observed. Before October 2000, 104 recipients received the conventional dose of immunosuppressants; thereafter, 96 recipients received lower dose treatment. Doses of immunosuppressive agents, the incidence of acute rejection and pulmonary infection, and patient and graft survival rates were compared between the two groups.Results. Doses of mycophenolate mofetil (MMF) and cyclosporine A (CsA) administered in the conventional dose group were significantly higher than in the lower dose group at 3 months posttransplant, as was prednisone at 6 months posttransplant. The incidence of acute rejection and subclinical rejection that was biopsy-proven or diagnosed by clinical manifestations was 17.3% and 19.8%, respectively, in the conventional dose group and the lower dose group within the first 6 months, and no significant difference was noted (P=0.55). The incidence of pulmonary infection, especially severe infection, was much higher in the conventional treatment group (40.1% and 26.9%, respectively) than that in the lower dose group (11.5% and 5.2%, respectively), and the differences were statistically significant (P<0.001). The corresponding 1-year survival rate of patients was 87.4% and 97.9% (P<0.01), and that of renal grafts was 85.5% and 96.9% (P<0.01), for patients receiving conventional dose and lower dose immunosuppressive drugs, respectively. The rate of death with a functioning allograft caused by infection in the conventional dose group was significantly higher than that in the lower dose group (12.5% vs. 0%, P<0.01).Conclusions. The regimen of lower dose MMF, CsA, and prednisone in combination can significantly reduce the incidence of pulmonary infection, especially severe pulmonary infection, without increasing the incidence and severity of allograft rejection.

Comparing Antihypertensive Effect and Plasma Ciclosporin Concentration Between Amlodipine and Valsartan Regimens in Hypertensive Renal Transplant Patients Receiving Ciclosporin Therapy

Conversion from cyclosporine to sirolimus in chronic renal allograft dysfunction: a 4-year prospective study.

The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.

Correlation Factors Influencing Blood Concentration of Ciclosporin A in Patients Underwent Liver Trans Plantation

Clinical Analysis of 2520 Renal Transplantations in One Center

Correlation Between Blood Concentrations of Ciclosporin and Its Adverse Drug Reactions in Immunosuppressive Treatment of Hematopoietic Stem Cell Transplantation Recipients

Study of Ciclosporin Concentration in Blood of Kidney Transplantation Recipients

Anti-virus efficacy of cyclosporine in renal transplant recipients with hepatitis C virus-RNA positive

Population Pharmacokinetic Study Of Cyclosporine In Hematopoietic Stem Cell Transplant Recipients

Improved Clinical Outcomes in Chinese Renal Allograft Recipients Receiving Lower Dose Immunosuppressants

The comparison of clinical effects and safety of Neoral, New Cyspin, TianKe in renal allograft transplantation

Influence of the MDR1 Haplotype and CYP3A5 Genotypes on Cyclosporine Blood Level in Chinese Renal Transplant Recipients.

Population Pharmacokinetics Of Cyclosporine In Clinical Renal Transplant Patients

Cyclosporine microemulsion C2 monitoring in Chinese heart transplant recipients

PXR Haplotype Clusters Will Affect the Pharmacokinetics of Ciclosporin in Chinese Renal Transplant Recipients

Cardiac and vascular abnormalities in renal transplant patients: differential effects of cyclosporin and azathioprine

Meta-analysis on Inhibitory Effectiveness of Tacrolimus and Ciclosporin on Acute Rejection in Patients after Kidney Transplatation

Time-dependent Clearance of Cyclosporine in Adult Renal Transplant Recipients: A Population Pharmacokinetic Perspective

Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation

A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

Joint packet- and call-level soft handoff in CDMA wireless cellular networks